Head and Neck Cancer: Clinical Trials

25 trials for Head and Neck Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 4 unknown, 2 active not recruiting, 2 recruiting. 25 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 425Completed 14, Unknown 4, Active not recruiting 2, Recruiting 2, Withdrawn 2, Terminated 1

Follow Head and Neck Cancer: new trials by email Literature Review of Head and Neck Cancer trials Research Report on Head and Neck Cancer

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
Enoxaparin, Apixaban - Venous Thromboembolism, Head and Neck Cancer
Phase 4RecruitingKiranya Arnold762025-10-012025-10-08
Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy
Echo-guided Botox injection, echo-guided normal saline injection - Trismus, Head and Neck Cancer
Phase 4RecruitingNational Taiwan University Hospital1202024-12-012024-12-16
Impact of the Oral Microbiota on Relapse in HNSCC Patients
buccal swabs - Head and Neck Cancer
Phase 4Active not recruitingInstitut Sainte Catherine1002024-11-182025-02-04
Effects of Minimal-Flow Sevoflurane and Multimodal Analgesia in Head and Neck Cancer Surgery
Multimodal analgesia using dexmedetomidine-ketamine-lidocaine mixture, Minimal flow sevoflurane - Head and Neck Cancer, Anesthesia
Phase 4UnknownNational Taiwan University Hospital602024-08-012024-07-26
Mood Disorders in Head and Neck Cancer Patients
Venlafaxine - Depressive Disorder, Head and Neck Cancer
Phase 4WithdrawnUniversity of Alabama at Birmingham2024-01-052025-02-04
Benzydamine Oromucosal Solution in Oral Mucositis (BOOM)
Benzydamine Hydrochloride 0.15% w/v oromucosal solution - Radiation-Induced Mucositis, Head and Neck Cancer
Phase 4CompletedAziende Chimiche Riunite Angelini Francesco S.p.A1002021-12-062022-11-16
A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma
Nimotuzumab, cis-platinum, IMRT combine with cisplatin concurrent chemotherapy - Head and Neck Cancer
Phase 4Active not recruitingBiotech Pharmaceutical Co., Ltd.1712021-05-152025-03-17
Nutrition and Pharmacological Algorithm for Oncology Patients Study
Dexamethasone, Dronabinol, Mirtazapine - Oncologic Complications, Quality of Life
Phase 4TerminatedMontefiore Medical Center12021-03-012022-11-16
Individualization of Nutritive Sensory Support Of Radiation Therapy
Oral nutritional supplements (ONS) with a cooling effect + ONS without a sensor component and taste + standard diet, ONS without a sensor component and taste + standard diet, Standard diet - Radiotherapy; Complications, Head and Neck Cancer
Phase 4CompletedNational Medical Research Radiological Centre of the Ministry of Health of Russia1002020-12-152023-03-24
Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients
Fentanyl, Morphine - Pain, Nasopharyngeal Carcinoma
Phase 4UnknownJiarong Chen, MD3002020-12-012020-07-29
Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and Chemoradiotherapy
Anlotinib hydrochloride capsules - Head and Neck Cancer
Phase 4UnknownSun Yat-sen University302020-09-012020-08-28
Multimodal Pain Study in Free Flap Patients
Tylenol, Oxycodone, Morphine - Head and Neck Cancer, Analgesia
Phase 4CompletedUniversity of Kansas Medical Center302019-11-012026-07-07
Pre-Operative Pregabalin for Post-Operative Pain in Head and Neck Cancer Surgery
Pregabalin 150mg, Placebo - Head and Neck Cancer, Pain, Postoperative
Phase 4WithdrawnAugusta University2019-03-222020-07-09
Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery
Levobupivacaine, Saline Solution - Head and Neck Cancer, Pain, Musculoskeletal
Phase 4CompletedRegion Skane242018-09-012021-04-08
Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients
Gabapentin, Placebo - Head and Neck Cancer, Acute Pain
Phase 4CompletedWashington University School of Medicine1232016-06-242018-08-08
A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study
Salivary equivalent, Aequasyal, Biotene - Xerostomia, Hyposalivation
Phase 4CompletedUnither Pharmaceuticals, France2102012-01-012014-01-29
Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE)
Erbitux®, Fractionated Radiotherapy - Head and Neck Cancer
Phase 4CompletedUniversity of Heidelberg Medical Center1392011-06-012022-05-25
The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound
silver-releasing dressings - Head and Neck Neoplasms, Head and Neck Cancer
Phase 4UnknownNational Taiwan University Hospital702009-01-012009-05-19
Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
Epinephrine, Norepinephrine, Dobutamine - Oral Cancer, Head and Neck Cancer
Phase 4CompletedOxford University Hospitals NHS Trust252008-10-012011-08-16
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
smoking cessation intervention, bupropion hydrochloride, gene expression analysis - Bladder Cancer, Cervical Cancer
Phase 4CompletedLisa Sanderson Cox, PhD5402007-12-012017-11-13

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Head and Neck Neoplasms (25)  ·  Lung Neoplasms (4)  ·  Esophageal Neoplasms (3)  ·  Mouth Neoplasms (3)  ·  Pain, Postoperative (3)  ·  Pancreatic Neoplasms (3)  ·  Agnosia (2)  ·  Carcinoma, Hepatocellular (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Renal Cell (2)  ·  Hypopharyngeal Neoplasms (2)  ·  Hypotension (2)  ·  Kidney Neoplasms (2)  ·  Laryngeal Neoplasms (2)  ·  Leukemia (2)

Broader conditions

Neoplasms by Site (25)  ·  Neoplasms (24)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Signs and Symptoms (7)  ·  Stomatognathic Diseases (7)  ·  Mouth Diseases (6)  ·  Neurologic Manifestations (6)  ·  Digestive System Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Digestive System Neoplasms (4)  ·  Gastrointestinal Diseases (4)  ·  Lung Diseases (4)  ·  Neoplasms by Histologic Type (4)  ·  Otorhinolaryngologic Diseases (4)  ·  Pathologic Processes (4)

Interventions

Gabapentin (2)  ·  Morphine (2)  ·  Norepinephrine (2)  ·  Acetaminophen (1)  ·  Benzydamine (1)  ·  Bleomycin (1)  ·  Bupivacaine (1)  ·  Bupropion (1)  ·  Cetuximab (1)  ·  Cisplatin (1)  ·  Counseling (1)  ·  Dexamethasone (1)  ·  Diet Therapy (1)  ·  Dietary Supplements (1)  ·  Dobutamine (1)

Sponsors

National Taiwan University Hospital (3)  ·  Augusta University (1)  ·  Aziende Chimiche Riunite Angelini Francesco S.p.A (1)  ·  Biotech Pharmaceutical Co., Ltd. (1)  ·  Fox Chase Cancer Center (1)  ·  Inovio Pharmaceuticals (1)  ·  Institut Sainte Catherine (1)  ·  Jiarong Chen, MD (1)  ·  Kiranya Arnold (1)  ·  Lisa Sanderson Cox, PhD (1)  ·  Montefiore Medical Center (1)  ·  Mt. Sinai Medical Center, Miami (1)  ·  National Medical Research Radiological Centre of the Ministry of Health of Russia (1)  ·  Oxford University Hospitals NHS Trust (1)  ·  Region Skane (1)

Countries

United States (9)  ·  France (3)  ·  China (2)  ·  Taiwan (2)  ·  Finland (1)  ·  Germany (1)  ·  Hungary (1)  ·  Poland (1)  ·  Russia (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Corinne Bouteloup, Doctor (1)  ·  James K Byrd, MD (1)  ·  Jessica Grayson, MD (1)  ·  Jiarong Chen, PhD (1)  ·  Justin Tang, MD (1)  ·  Lisa S. Cox, PhD (1)  ·  Lisa Shnayder, MD (1)  ·  Louise Walther Sturesson, MD, PhD (1)  ·  Marie-Paule Vasson, Professor (1)  ·  Melanie Townsend, M.D. (1)  ·  Michael A Samuels, MD (1)  ·  Ming-Hui Hung, MD (1)

Results publications

PMID 21266057, PMID 21775497, PMID 22241828, PMID 22929242, PMID 23733379, PMID 23855804, PMID 25575640, PMID 29710075, PMID 33300144, PMID 34611902, PMID 34791718, PMID 37230961, PMID 39868569

NIH funding

2008 (1), 2019 (1), R01CA091912 (1)